Education
About Us
Working with TipRanks
Follow Us
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
RESEARCH TOOLSreports
Bright Minds Biosciences (DRUG) Ownership Overview
30.50% Insiders
54.65% Other Institutional Investors
0.18% ETFs
14.68% Public Companies and
Individual Investors
The ownership structure of Bright Minds Biosciences (DRUG) stock is a mix of institutional, retail, and individual investors. , 30.50% is owned by Insiders, and 14.68% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 07, 2025 | Nils Bottler Non Executive,director | xxxxxxxxxxxxx | $180985 |
| Dec 11, 2024 | Jan Torleif Pedersen Chief Scientific Officer | xxxxxxxxxxxxx | C$1411795 |
| Nov 14, 2024 | Nils Bottler Non Executive,director | xxxxxxxxxxxxx | $653408 |
| Nov 12, 2024 | Ryan Cheung Chief Financial Officer | xxxxxxxxxxxxx | C$399010 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,059,331 | Insider | 15.04% | 37,902,863 | |
| 1,004,900 | Insider | 14.27% | 35,955,322 | |
| 460,829 | Institution | 6.54% | 16,488,462 | |
| 403,649 | Institution | 5.73% | 14,442,561 | |
| 60,000 | Insider | 0.85% | 2,146,800 | |
| 19,750 | Insider | 0.28% | 706,655 | |
| 12,381 | Institution | 0.18% | 442,992 | |
| 4,609 | Insider | 0.07% | 164,910 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Bright Minds Biosciences (DRUG)?
According to the latest TipRanks data, approximately 54.65% of the company's stock is held by institutional investors, 30.50% is held by insiders, and 14.68% is held by retail investors.
What percentage of Bright Minds Biosciences (DRUG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 54.65% of Bright Minds Biosciences (DRUG) stock is held by institutional investors.
What percentage of Bright Minds Biosciences (DRUG) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.68% of Bright Minds Biosciences (DRUG) stock is held by retail investors.
Who owns the most shares of Bright Minds Biosciences (DRUG)?
Cormorant Asset Management LP owns the most shares of Bright Minds Biosciences (DRUG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.